Physician profile
Eileen Fermin
NPI 1265553325
$4,904.52
in general payments reported to CMS, 2019-2025
37 companies · $1,787 in 2025
The $1,787 reported for 2025 was more than what 94% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $167 · 2021: $249 · 2022: $316 · 2023: $907 · 2024: $1,117 · 2025: $1,787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,300 · Travel and Lodging: $336 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,299.62 |
| Travel and Lodging | $336.38 |
| Education | $174.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,023.67 | 2022-2025 | Watchman Access System, Watchman Flx |
| Astellas Pharma US INC | $633.79 | 2019-2023 | Veozah |
| Astrazeneca Pharmaceuticals LP | $499.70 | 2023-2025 | Farxiga, Lokelma, Airsupra |
| Novo Nordisk INC | $415.55 | 2019-2025 | Wegovy, Ozempic |
| Atricure, INC. | $326.65 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Abbvie INC. | $243.70 | 2019-2025 | |
| Pfizer INC. | $161.08 | 2019-2024 | |
| Corcept Therapeutics | $160.47 | 2025 | Korlym |
| Eisai INC. | $146.87 | 2021-2025 | |
| Edwards Lifesciences Corporation | $139.72 | 2024 | Sapien 3 Ultra Resilia |
| Lilly USA, LLC | $124.53 | 2019-2023 | Mounjaro |
| Glaxosmithkline, LLC. | $103.21 | 2023-2024 | Shingrix, Arexvy |
| Exact Sciences Corporation | $101.39 | 2023-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $73.90 | 2024-2025 | Gemtesa |
| Sanofi-Aventis U.S. LLC | $72.52 | 2022-2023 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Fermin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.